David Rosmarin, MD: Updates in Topical and Systemic Vitiligo Treatment
Dr. Rosmarin discusses his vitiligo session from November’s Masterclasses in Dermatology Meeting, in which he reviewed recent insights on maintaining and building upon initial treatment response with long-term use of ruxolitinib cream as well as oral JAKs on the horizon for vitiligo.
JCAD December 2024 Issue Highlights with James Del Rosso, DO
JCAD Clinical Editor-in-Chief, James Del Rosso, DO, shares his thoughts on some of the newly published articles found in the December 2024 issue of The Journal of Clinical and Aesthetic Dermatology. Read the full issue here.
David Altman, MD: Phenotypic Shift during Treatment of Plaque Psoriasis with Ixekizumab
Dr. Altman discusses a new article published in the November 2024 issue of JCAD that presents a case of a patient with longstanding psoriasis vulgaris who developed an atopic dermatitis-like eruption following long-term IL-17A inhibitor therapy. Read the full article below.
James Song, MD: Personalizing Treatment for Atopic Dermatitis
Looking to the future of AD treatment, Dr. Song discusses the unmet need of predicting treatment responses in patients with atopic dermatitis, with the aim of avoiding the trial-and-error process of trying multiple medications.
Cheri Frey, MD: Targeting Hyperpigmentation
Dr. Frey reviews her session presented at the Science of Skincare Summit 2024.